# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
RBC Capital analyst Ben Hendrix maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Sector Perform and raises the price ...
Deutsche Bank analyst Pito Chickering maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Buy and raises the price targe...
UBS analyst A.J. Rice maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Sell and raises the price target from $1.7 to ...
Revised Full Year 2024 Guidance The following is our updated guidance reflecting our current expectations for revenue and Adju...
Aveanna Healthcare Hldgs (NASDAQ:AVAH) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate...
djusted EBITDA of greater than $150 million, updated from prior guidance of Adjusted EBITDA between $146 million and $150 million